PASG - Passage Bio, Inc. Projected Future Earnings
Interim test results for rare brain pathologies are driving the momentum for Passage Bio, Inc. (PASG). The future profit trajectory demonstrates how the value is maintained at . Passage Bio, Inc. (PASG) relies on inelastic demand in the orphan segment thanks to AAV vectors. High barriers to entry and the capital intensity of developing DNA gene delivery methods ensure the company's leadership in a protected niche.
Analytical breakdowns and data insights for company Passage Bio (PASG)
- price and consensus price forecast:
- market capitalization statistics:
- book capitalization indicators:
- debt and liquidity details:
- net income and valuation ratios data:
PASG - Company Net Income|Projected Future Earnings Passage Bio, Inc.|PASG - Business Payback Period|Future Price to Earnings Passage Bio Inc.|PASG - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Passage Bio|PASG - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Passage Bio|PASG - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months passagebio.com|PASG - Earnings per share growth this year|Earnings growth forecast for next year Passage Bio, Inc.
Analysis of all company metrics:Passage Bio, Inc., PASG
The calculation formula for this indicator is based on the difference between expected operating revenues and total costs. This metric measures net profit potential, determining the asset's fundamental value. For Passage Bio, Inc. (PASG), the confidence of neurobiologists and support from funds mitigate the risks associated with realizing these forecasts. However, the organization's high future profitability may trigger an overpayment for shares. Analyze the dynamics along this curve to assess the balance between growth and price.
Competitors of Passage Bio, Inc.
Expected Profit Biogen Inc.|neurocrine.com - Forward Earnings|Projected Future Earnings RGC|Projected Future Earnings Axsome (AXSM)|Expected Profit ACADIA Pharmaceuticals Inc ACAD|Company Profit Forecast Xenon Corp (XENE)|VKTX - Expected Profit|Company Profit Forecast supernus.com SUPN|CPRX: Projected Future Earnings|Denali (DNLI) - Projected Future Earnings|HRMY (Harmony Pharma) - Projected Future Earnings|BHVN - Projected Net Profit|Projected Future Earnings AMLX|TRVI - Expected Net Profit|Praxis Precision Medicines, Inc. - Future Profit|Expected Net Income AVXL|CeriBell Corp - Projected Future Earnings|PRTA: Expected Profit|ALEC: Projected Future Earnings|ANNX - Company Profit Forecast|Expected Profit Omeros Corp|Expected Net Profit Neurogene Inc NGNE|Future Profit ACIU (AC Immune Corp)|VYGR (Voyager Corp) - Expected Net Income|Projected Future Earnings NMRA (Neumora Therapeutics)|Company Profit Forecast scilexholding.com (SCLX)|TVGN - Expected Profit|ACOG (Alpha Cognition) - Net Profit Forecast|CGTX: Projected Future Earnings|Future Profit Inhibikase Pharma|Future Profit SAVA|Assertio Therapeutics (ASRT) - Company Profit Forecast|Expected Profit Coya Therapeutics, Inc. (COYA)|VTGN: Forward Earnings|Projected Future Earnings OVID (Ovid Therapeutics)|Projected Future Earnings Acumen Pharmaceuticals, Inc ABOS|CRVO - Expected Profit|Company Profit Forecast Alterity Therapeutics ATHE|CLNN: Projected Future Earnings|Projected Net Profit PepGen PEPG|Expected Profit Jupiter Neurosciences|Net Profit Forecast RLMD (Relmada Corp)|Projected Future Earnings ANVS|GRCE - Expected Net Profit|Firefly Neuroscience - Future Profit|Projected Future Earnings ANEW Medical KLTO|NRSN - Expected Profit|Expected Net Income RVPH (Reviva Pharmaceuticals, Inc.)|metaviatx.com (MTVA) - Expected Profit|Expected Net Profit neuraxis.com (NRXS)|Expected Profit Helius Medical Technologies, Inc.|Neuphoria - Forward Earnings|Projected Future Earnings NERV|Projected Future Earnings Athira Pharma Corp (ATHA)|Expected Profit Addex Therapeutics ADXN|Company Profit Forecast Alzamend Neuro Inc. (ALZN)|CYCN - Expected Profit|Company Profit Forecast Protagenic Therapeutics PTIX|KTTA: Projected Future Earnings|Cortigent (CRGT) - Projected Future Earnings|ATXI (Avenue Therapeutics) - Projected Future Earnings|BCLI - Projected Net Profit|Projected Future Earnings CARA|CHRO - Expected Net Profit|Eliem Therapeutics Inc. - Future Profit|Expected Net Income ITCI|Longboard Pharmaceuticals - Projected Future Earnings|MRNS: Expected Profit|NKGN: Projected Future Earnings|NRBO - Company Profit Forecast|Expected Profit Sage Therapeutics, Inc|Expected Net Profit Synaptogenix, Inc SNPX|Future Profit TRVN (Trevena, Inc.)|VIGL (vigilneuro.com) - Expected Net Income|Projected Future Earnings WENA (Anew Medical, Inc.)|Company Profit Forecast Cerevel Therapeutics Inc (CERE)
